N@N

XOMA, BMRA, ATRA, HFC, OPHT, Expected to Trade Lower After Bearish Insider Trading

December 27, 2016 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. XOMA Corporation (NASDAQ:XOMA), Biomerica Inc. (NASDAQ:BMRA), Atara Biotherapeutics Inc. (NASDAQ:ATRA), HollyFrontier Corporation (NYSE:HFC), Ophthotech Corporation (NASDAQ:OPHT) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

  Symbol  Company Name                     Insider Name                     Role     Shares      Insider Score  Avg 6 Month Return  # of Dec. 
  XOMA    XOMA Corporation                 Varian John W                    D        13,549      90             -12.3%              29        
  BMRA    Biomerica Inc.                   Moore, Janet C                   CFO      9,780       92             -49.8%              3         
  ATRA    Atara Biotherapeutics Inc.       Ciechanover, Isaac E             CEO      4,800       100            -32.6%              23        
  HFC     HollyFrontier Corporation        Jennings, Michael C              OD       6,529       84             -11.1%              7         
  OPHT    Ophthotech Corporation           Sblendorio, Glenn P              CO       1,079       85             -22.1%              3         

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

XOMA Corporation (NASDAQ:XOMA) - XOMA Corporation, a development stage biotechnology company, discovers, develops, and commercializes antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company s product candidates include XOMA 358, a human negative allosteric modulating insulin receptor antibody is in phase 2 proof-of-concept study for treating congenital hyperinsulinism and post-meal hypoglycemia in post-bariatric surgery patients; XOMA 129, a potent fragment of a monoclonal antibody is under preclinical testing to treat patients with acute severe hypoglycemia; XOMA 213, a allosteric inhibitor for use in treating prolactinoma and anti-psychotic-induced hyperprolactinemia. It also licenses antibody discovery, optimization, and development technologies, including Antibody Discovery Advanced Platform Technologies, ModulX, and OptimX. The company has research and development collaboration and licensing agreements with Novartis AG; Novo Nordisk A/S; Takeda Pharmaceutical Company Limited; and Pfizer Inc. XOMA Corporation was founded in 1981 and is headquartered in Berkeley, California..

Biomerica Inc. (NASDAQ:BMRA) - Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions worldwide. Its diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. The company primarily focuses on products for gastrointestinal, food intolerances, diabetes, and esoteric tests. Biomerica, Inc. offers its products hospital and clinical laboratories, medical research institutions, medical schools, pharmaceutical companies, chain drugstores, wholesalers, and physicians' offices, as well as to distributors. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California..

Atara Biotherapeutics Inc. (NASDAQ:ATRA) - ATRATECH INC.

HollyFrontier Corporation (NYSE:HFC) - .

Ophthotech Corporation (NASDAQ:OPHT) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---